INFORMATION FOR SHAREHOLDERS

INFORMATION FOR SHAREHOLDERS

SHARE CAPITAL AND SHAREHOLDERSHIP

The share capital of I.M.D. International Medical Devices S.p.A. amounts to Euro 4,000,000 and consists of a total of 17,646,750 ordinary shares with no nominal value, divided as follows:

Shareholder n. of Shares %
Alefra Srl* 11.829.211 67,03%
Aniello Aliberti* 1.438.023 8,15%
Dornier Medtech GmbH* 1.676.441 9,50%
Own Shares 325.575 1,85%
Market 2.377.500 13,47%
Total 17.646.750 100,00%

*Shareholders Aniello Aliberti, Alefra S.r.l. (a company wholly owned by Aniello Aliberti), and Dornier Medtech GmbH have entered into a lock-up agreement with the Global Coordinator Banca Akros S.p.A., valid for up to 12 months from the start date of trading.


DISSEMINATION OF REGULATED INFORMATION

The company uses the eMarket SDIR dissemination system managed by Teleborsa S.r.l., located at Piazza di Priscilla 4, Rome.


INFORMATIONAL OBLIGATIONS OF SIGNIFICANT SHAREHOLDERS

In accordance with the Euronext Growth Milan Issuer Regulations approved and published by Borsa Italiana, along with subsequent amendments and integrations ("Euronext Growth Milan Issuer Regulations"), anyone holding at least 5% of a category of shares in I.M.D. International Medical Devices S.p.A. is a "Significant Shareholder."

The reaching or exceeding of the thresholds of 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6%, and 90% of the share capital, as well as reductions below these thresholds, constitute, according to the Euronext Growth Milan Issuer Regulations, a "Substantial Change" that must be communicated by Significant Shareholders (or by shareholders who, as a result of the transaction, have acquired such status) to the administrative body of I.M.D. International Medical Devices S.p.A.

For this purpose, the Significant Shareholder (or the shareholder who, as a result of the transaction, has acquired such status) must promptly notify I.M.D. International Medical Devices S.p.A. of the Substantial Change within 4 trading days from the day they become aware of the transaction capable of triggering the obligation, regardless of the execution date, or the date on which the obligated party becomes aware of events leading to changes in share capital, indicating:


One's identity;
The date on which the Substantial Change in shareholdings occurred.
The nature and extent of the Significant Shareholder's participation in the transaction; in the case of the issuance of multiple voting shares, the number of voting rights and the number of ordinary shares held.

Communication must be made using the attached form, to be sent both via email and via PEC to the following addresses respectively: imdspa@legalmail.it

Euronext Growth Advisor and Consultants

Issuer
EGA, Global Coordinator e Specialist – Banca Akros
Financial Advisor - IRTOP Consulting
Legal and Tax Consultant - LCA
Financial Audit for Listing - RSM
Audit Firm - KPMG


I.M.D. International
Medical Devices S.p.A.

With over 40 years of experience in MedTech, IMD Group is engaged in the development, production, and distribution of a wide range of X-ray diagnostic systems for key clinical applications in the field of radiology.

THE HEADQUARTER

Via E. Fermi 26
24050 Grassobbio - BG - ITALY

info@imdgroup.it
PEC: imdspa@legalmail.it
Tel: +39 035 65.94.811
Fax: +39 035 65.94.899

Cap. Sociale € 4.000.000 int. vers.